Aptevo Therapeutics Inc. (APVO): Price and Financial Metrics
APVO Price/Volume Stats
| Current price | $4.78 | 52-week high | $658.60 |
| Prev. close | $4.96 | 52-week low | $4.30 |
| Day low | $4.78 | Volume | 58,400 |
| Day high | $5.18 | Avg. volume | 162,079 |
| 50-day MA | $13.33 | Dividend yield | N/A |
| 200-day MA | $108.50 | Market Cap | 1.94M |
APVO Stock Price Chart Interactive Chart >
Aptevo Therapeutics Inc. (APVO) Company Bio
Aptevo Therapeutics, a biotechnology company, provides oncology and hematology therapeutics. Its marketed products include WinRho SDF for the treatment of autoimmune platelet disorders, as well as for the treatment of hemolytic disease of the newborn; and HepaGam B used for the prevention of hepatitis-B recurrence following liver transplantation in HBsAg-positive liver transplant patients, and for the treatment following exposure to hepatitis-B. The company was spun off from Emergent BioSolutions Inc. in 2016 and is based in Seattle, Washington.
APVO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APVO Price Returns
| 1-mo | -38.72% |
| 3-mo | -90.59% |
| 6-mo | -97.54% |
| 1-year | -99.24% |
| 3-year | -100.00% |
| 5-year | -100.00% |
| YTD | -94.45% |
| 2024 | -98.54% |
| 2023 | -92.20% |
| 2022 | -70.52% |
| 2021 | -78.53% |
| 2020 | 299.98% |